Tagged With Alzheimer’s

A drug for treating prostate cancer has been linked with increased risk of dementia, study finds

Bill Gates says there could be a way to predict Alzheimer’s using a voice app that listens for 'warning signs'

Your multivitamins and brain-boosting pills may be suspect, and regulators are cracking down on the $40 billion industry

The 96-year-old who won the 2018 Nobel Prize in physics reveals his science-backed secret to staying sharp in old age

Drug giant Pfizer isn't ready to abandon neuroscience — here's its $150-million ‘star cluster’ strategy for betting on promising brain drug startups

This is what it's like to care for someone with dementia

15 common misconceptions and surprising realities about dementia and Alzheimer's disease

We just got more information on the first positive Alzheimer's trial in years — here's what you need to know

A company that's taking a new approach to tackling Alzheimer's is moving into human trials after raising $133 million

Bill Gates and a group of investors are backing a $30 million 'venture philanthropy' fund to tackle Alzheimer's

Meet the 29-year-old who founded a company that's using technology to find treatments for diseases thought to be incurable

Astronaut Buzz Aldrin is embroiled in a public feud with his kids over dementia — and the future of his legacy

Herpes may play a role in developing Alzheimer's, a new study suggests — reigniting a controversial theory about what causes the disease

Even one night of bad sleep causes dangerous changes in your brain, a new study found

The search for a new Alzheimer's treatment just hit another setback

A study of people over 90 linked drinking with a long life -- but there's a sizable catch when it comes to your brain health

The CEO of a biotech founded by a 32-year old is stepping down after 10 months -- and the stock is crashing

Science has created a simple blood test for Alzheimer’s

Biotech execs tell us why 2018 is a good year to invest in the brain

A biotech founded by a 32-year-old just hit another setback -- and the stock got chopped in half